Study Stopped
A corporate decision to terminate the study
Shamir Aspheric Ophthalmic Lenses (MyLens) for Myopic Control Clinical Trial
1 other identifier
interventional
61
1 country
1
Brief Summary
The aim of this clinical trial is to compare the rate of myopic progression in children wearing aspheric (MyLens) and spherical/ toric ophthalmic lenses. The proposed lens design is an aspheric lens which is supposed to slow myopic progression in children by unique asphericity (proprietary information). Myopic progression is quantified by changes in axial length (AL) and cycloplegic refractive error (Rx) will be monitored for 6-12 months (6 months crossover) with double-masking. Peripheral refraction and ocular aberration will be evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2016
CompletedFirst Submitted
Initial submission to the registry
March 2, 2016
CompletedFirst Posted
Study publicly available on registry
March 7, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2017
CompletedFebruary 25, 2019
February 1, 2019
1.6 years
March 2, 2016
February 21, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in axial length in 6-12 months
Evaluate the changes in cycloplegic axial length in the eye with aspheric lens (MyLens) compared to the other eye with single vision spheric/toric lens
Every 6 months for a period of 1 year
Study Arms (2)
Aspheric lens
EXPERIMENTALAn aspheric lens which is supposed to slow myopic progression in children by unique asphericity (proprietary information)
Single vision spheric/toric lenses
NO INTERVENTIONControl: single vision spheric/toric lenses
Interventions
By using a special asphericity, MyLens is customized for various prescriptions and vision directions based on specific measurements, intended for myopia correction and control
Eligibility Criteria
You may qualify if:
- Myopia between 0.75 \~ - 4.50 D and with-the-rule astigmatism not more than 1.50 D
- Difference between eyes, no more than 1.25 spherical equivalent
- Best corrected visual acuity (VA) is equal to or better than 0.10 in logMAR scale (Snellen VA 6/7.5 or better)
- Eyes straight at distance and near with best subjective correction
- Willing to be randomized and wear the study spectacles according to the instructions from practitioner
- Willing to come back for follow up in the Optometry Clinic during the study period
You may not qualify if:
- Abnormal ocular and general health
- Prior myopic treatment (e.g. refractive surgery and progressive lens wear for myopic control) before and during the study period
- History of rigid contact lenses (including orthokeratology lenses) wearing
- Systemic condition which might affect refractive development (for example, Down syndrome, Marfan's syndrome)
- Ocular conditions which might affect the refractive error (for example, cataract, ptosis).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The Hong Kong Polytechnic Universitylead
- Shamir Optical Industry Ltdcollaborator
Study Sites (1)
School of Optometry, The Hong Kong Polytechnic University
Kowloon, Hong Kong
Related Publications (5)
Edwards MH, Li RW, Lam CS, Lew JK, Yu BS. The Hong Kong progressive lens myopia control study: study design and main findings. Invest Ophthalmol Vis Sci. 2002 Sep;43(9):2852-8.
PMID: 12202502BACKGROUNDGwiazda J, Hyman L, Hussein M, Everett D, Norton TT, Kurtz D, Leske MC, Manny R, Marsh-Tootle W, Scheiman M. A randomized clinical trial of progressive addition lenses versus single vision lenses on the progression of myopia in children. Invest Ophthalmol Vis Sci. 2003 Apr;44(4):1492-500. doi: 10.1167/iovs.02-0816.
PMID: 12657584BACKGROUNDHasebe S, Jun J, Varnas SR. Myopia control with positively aspherized progressive addition lenses: a 2-year, multicenter, randomized, controlled trial. Invest Ophthalmol Vis Sci. 2014 Sep 30;55(11):7177-88. doi: 10.1167/iovs.12-11462.
PMID: 25270192BACKGROUNDHasebe S, Ohtsuki H, Nonaka T, Nakatsuka C, Miyata M, Hamasaki I, Kimura S. Effect of progressive addition lenses on myopia progression in Japanese children: a prospective, randomized, double-masked, crossover trial. Invest Ophthalmol Vis Sci. 2008 Jul;49(7):2781-9. doi: 10.1167/iovs.07-0385.
PMID: 18579755BACKGROUNDYang Z, Lan W, Ge J, Liu W, Chen X, Chen L, Yu M. The effectiveness of progressive addition lenses on the progression of myopia in Chinese children. Ophthalmic Physiol Opt. 2009 Jan;29(1):41-8. doi: 10.1111/j.1475-1313.2008.00608.x.
PMID: 19154279BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pauline Cho, PhD
The Hong Kong Polytechnic University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 2, 2016
First Posted
March 7, 2016
Study Start
January 1, 2016
Primary Completion
August 1, 2017
Study Completion
August 1, 2017
Last Updated
February 25, 2019
Record last verified: 2019-02
Data Sharing
- IPD Sharing
- Will share
The demographic data of subjects recruited in this study will be disclosed in this website